Functional Microbiomics Core

功能微生物组学核心

基本信息

  • 批准号:
    10492098
  • 负责人:
  • 金额:
    $ 75.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-03-01 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract In this Phase 2 of the Functional Microbiomics, Inflammation and Pathogenicity COBRE, the primary goal of the Functional Microbiomics Core (FMC) is unchanged. We will sustain and enhance the well-established integrated service center that functions as a critical resource for the Research Project Leaders (RPLs) as a priority, and secondarily for all investigators of the Center. Since all new COBRE projects also utilize mouse models to explore the inter-relationships between inflammation and pathogenesis, and the contribution of microbiota to this process, our well-established germ-free and gnotobiotic mice facility (GMF) will continue to play a central role in services provided by the FMC. We will continue to provide anaerobic culturing of mixed and/or mono bacterial strains to facilitate the specific colonization of the germ-free mice. 16S ribosomal DNA will be profiled with the in-house developed Oxford nanopore sequencing as well as PacBio-long read sequencing tools, and bioinformatic support provided. Our most extensively used resource; multiplex-based analysis of inflammatory mediators in biological samples, will continue to function using the Bio-Plex 200 (Bio-Rad) multiplex system. In addition, several recent advances allow us to augment the services provided by the FMC. First, the recently developed, highly successful rederivation service of transgenic and KO mouse models as germ-free, will greatly expand the scope and utility of the GMF. Related to this service is the development of a new area of research on the role of microbiota in Alzheimer’s Disease (AD) supported by an administrative supplement to the FMC from NIA/NIGMS. The GMF has already rederived several AD mouse models. For this project, the FMC also developed a suite of mouse behavior analysis models including the Morris Water Maze and Novel Object Recognition tests. These services will support all future ageing related research at the center including a new project on the role of edible-plant derived exosomes in restoring the integrity of the Blood Brain Barrier. We also now include imaging support, in particular Multiphoton Intravital Microscopy for imaging of live tissue and an In Vivo Imaging System (IVIS) for live mouse imaging. Besides functioning as a service center, another major goal of the FMC is to promote the education and training of researchers, primarily the RPLs. The FMC will also interact with other Core facilities at the University of Louisville, such as the Genomics, Metabolomics and Bioinformatics core facilities established with the support of other highly successful COBRE/INBRE programs. In particular, the newly funded Cancer Immunology and Immunotherapy COBRE-operated Functional Immunomics Core (FIC) facility also directed by Dr. Bodduluri has several joint initiatives with the FMC including the establishment of a histopathology service center. The FMC will work with these and other UofL resources in order to avoid duplication of equipment, and to train individual investigators in specific protocols, foster innovative protocol development and integrate analysis of data.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HARIBABU BODDULURI其他文献

HARIBABU BODDULURI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HARIBABU BODDULURI', 18)}}的其他基金

Functional Microbiomics Core-Bodduluri
功能微生物组学核心-Bodduluri
  • 批准号:
    10349568
  • 财政年份:
    2018
  • 资助金额:
    $ 75.81万
  • 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
  • 批准号:
    8433515
  • 财政年份:
    2009
  • 资助金额:
    $ 75.81万
  • 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
  • 批准号:
    8210894
  • 财政年份:
    2009
  • 资助金额:
    $ 75.81万
  • 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
  • 批准号:
    8015283
  • 财政年份:
    2009
  • 资助金额:
    $ 75.81万
  • 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
  • 批准号:
    7635082
  • 财政年份:
    2009
  • 资助金额:
    $ 75.81万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    7032234
  • 财政年份:
    2003
  • 资助金额:
    $ 75.81万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    6706978
  • 财政年份:
    2003
  • 资助金额:
    $ 75.81万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    6610703
  • 财政年份:
    2003
  • 资助金额:
    $ 75.81万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    6858582
  • 财政年份:
    2003
  • 资助金额:
    $ 75.81万
  • 项目类别:
REGULATION OF HIV-1 CORECEPTORS
HIV-1 辅助受体的调节
  • 批准号:
    6019921
  • 财政年份:
    2000
  • 资助金额:
    $ 75.81万
  • 项目类别:

相似海外基金

A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 75.81万
  • 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 75.81万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 75.81万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 75.81万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 75.81万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 75.81万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 75.81万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 75.81万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 75.81万
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    $ 75.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了